Navigation Links
IMPAX Presents at Movement Disorder Society's 11th International,Congress of Parkinson's Disease and Movement Disorders

.com.

"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995:

To the extent any statements made in this news release contain information that is not historical, these statements are forward-looking in nature and express the beliefs and expectations of management. Such statements are based on current expectations and involve a number of known and unknown risks and uncertainties that could cause IMPAX's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, possible adverse effects resulting from the delisting of and suspension of trading in IMPAX's stock, the SEC proceeding to determine whether to suspend or revoke the registration of IMPAX's securities under section 12 of the Securities Exchange Act, IMPAX's delay in filing its periodic reports subsequent to its Form 10-Q for the third quarter of 2004, IMPAX's ability to obtain sufficient capital to fund its operations, the difficulty of predicting FDA filings and approvals, consumer acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, IMPAX's ability to successfully develop and commercialize pharmaceutical products, IMPAX's reliance on key strategic alliances, the uncertainty of patent litigation, the availability of raw materials, the regulatory environment, dependence on patent and other protection for innovative products, exposure to product liability claims, fluctuations in operating results and other risks detailed from time to time in IMPAX's filings with the Securities and Exchange Commission. Forward-looking statements speak only as to the date on which they are made, and IMPAX undertakes no obligation to update publicly or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
2. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
3. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
4. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
5. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
6. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
7. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
8. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference

Post Your Comments:
(Date:11/27/2009)... Minn, Nov. 27 ACUO TECHNOLOGIES, ...ement software, data migration tools and services,...ent and Trademark Office has approved a patent app... a Computer Network." Acuo Technologies is pleased...ectual property. In general, the granted patent ap...
(Date:11/25/2009)..., Colo., Nov. 25 Heska C...of advanced diagnostic and specialty products to...ts with Roche Diagnostics Corporation for the supp...s for the veterinary market. ,, (Logo: htt...O ) ,, "Heska and Roche share the same passion ...
(Date:11/25/2009)..., Nov. 25 BioTrends Research Group...: Stelara report, the first in a multi-phase s...nch of Centocor Ortho-Biotech,s Stelara, from prod...ility. Each wave of the report provides quantitat...qualitative information from a subset of 20. The ...
Breaking Medicine Technology:Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Gene Linked to Breast Cancer Might Boost Heart Health 61379 1Gene Linked to Breast Cancer Might Boost Heart Health 61379 2Gene Linked to Breast Cancer Might Boost Heart Health 61379 3Rapid Cooling Might Help Heart Attack Patients 61376 1Rapid Cooling Might Help Heart Attack Patients 61376 2Sudden Cardiac Death Much More Likely to Strike Men 61373 1Sudden Cardiac Death Much More Likely to Strike Men 61373 2Sudden Cardiac Death Much More Likely to Strike Men 61373 3
(Date:11/26/2009)...tetrathiomolybdate (TM) has been shown in studies ..., a disease caused by an overload of copper, and c...y little, however, is known about how the drug wor...Northwestern University researchers now has provid...ture of TM bound to copper-loaded metallochaperone...
(Date:11/26/2009)...re letters from the North Pole, Textsanta.net lets...om Santa , North Pole, AK...fficiencies at the North Pole Santa Claus has adde...r the globe informed of his Christmas progress at ...h department have identified a large and growing p...
(Date:11/26/2009)...n Communications announces a highly effective and ...s struggling to make an economic recovery. , ...lu fears is the type of challenge that could send ...ing to Dr. David Benton, business growth expert an...tem – The Rfactor Intensive . “Fear...
(Date:11/25/2009)...Nov. 25 The Bartle Hall Convention...st medical clinic on Dec. 9-10, when Kansas City h...s for uninsured people. ,, "This free clinic ev...ecause it will extend over two days instead of jus...ekend," Sheri Wood, executive director of the Kans...
(Date:11/25/2009)...RNewswire/ - Sentinelle Medical Inc., a leading ma...ization software launches a suite of new leading e... imaging software platform at this year,s Radiolog...g in Chicago, Nov. 30 - Dec. 5, 2009 (Booth 5800, ... quality images generated by Sentinelle,s speciali...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4
...cessed Meat and Alcohol, WASHINGTON, Oct. 31 The...of developing cancer is much stronger now than,eve...day by the American,Institute for Cancer Research ...d convincing., Released today at a Washington new...
...th behavior change increasing, LYNDHURST, N.J., O... 3rd quarter of 2007, with agreements to offer new...ves at initial rollout,six million when programs a...cipation in client-sponsored population health,man...
...cancer death worldwide, the occurrence of esophage...and gender. Esophageal cancer is thought to be tri... interact with the host genome. Researchers have l...geal cancer. , One research article was published...
...) (ziconotide intrathecal infusion) as a First-L...ications, CHARLESTON, W.Va., Oct. 31 The 2007 Po...ading national pain management,physicians from the...romodulation, a neurology and pain,publication for...
...Call/ - BioMS Medical Corp (TSX:,MS), a leading de...), today,announced that Mr. Kevin Giese, President... and Renshaw 9th Annual Healthcare Conference in N...nual Healthcare Conference ----------------------...
...ians and other,healthcare providers have been cont...lthchannels forum,( http://www.healthcommunities.c...ly, the one-thousandth physician post was submitte...al, unbiased, and physician-developed and -monitor...
Other Medicine News:Health News:Landmark Report: Excess Body Fat Causes Cancer 2Health News:Landmark Report: Excess Body Fat Causes Cancer 3Health News:IncentOne Adds 14 New Clients Year to Date to Health and Productivity Division 2Health News:IncentOne Adds 14 New Clients Year to Date to Health and Productivity Division 3Health News:ADH2 and ALDH2 are associated with esophageal cancer 2Health News:Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain 2Health News:Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain 3Health News:Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain 4Health News:Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain 5Health News:BioMS Medical to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Health News:Free Site Offering Patient-Physician Dialog Reaches Milestone 2
Ovation BioNatural Pipette, two-stroke, fixed volume, 500L
Ovation BioNatural Pipette, one-stroke, fixed volume, 500L
Finnpipette Focus Fixed Volume, 500ul
...s a synonym for pipetting accuracy, a smooth strok...ting comfort. Its single, multifunctional button i...t as well as eject the tip. Product features:Eppen...and precision. Ejection sleeve can be removed to f...
Medicine Products: